Evidence map›Paper›PMID 42515009›Full record

ArticlePathogens (Basel, Switzerland)2026

Comparing the Risk of SARS-CoV-2 Immune Resistance Evolving Across Regions in the Americas with Differing Approaches to Public Health.

Kenichi W Okamoto, Luis F Chaves, Luke Bergmann, Rodrick D Wallace, Robert G Wallace

Abstract readComparative Study
In one paragraph

Article in Pathogens (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kenichi W OkamotoDepartment of Biology, University of St. Thomas, St. Paul, MN 55105, USA.ORCID 0000-0002-1889-4538
Luis F ChavesDepartment of Environmental and Occupational Health, School of Public Health and Department of Geography, Indiana University, Bloomington, IN 47405, USA.ORCID 0000-0002-5301-2764
Luke BergmannDepartment of Geography, University of British Columbia, Vancouver, BC V6T 1Z2, Canada.
Rodrick D WallaceDepartment of Epidemiology, New York State Psychiatric Institute, New York, NY 10032, USA.
Robert G WallaceAgroecology and Rural Economics Research Corps, St. Paul, MN 55105, USA.ORCID 0009-0007-7716-3499

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Public health policy foundationally impacts how pathogens spread, yet despite multiple pathogens of broader societal concern emerging, little research has examined how policy affects pathogen evolution. To evaluate this connection, we examine how varying public health approaches impact how viral immune susceptibility, including resistance to vaccines, evolves. Integrating evolutionary epidemiological modeling and critical geography, we compare how distinct public health responses early in the COVID-19 pandemic affected the potential evolution of immune evasion in SARS-CoV-2 across four territories: Costa Rica, Panama, Texas, and Uruguay. We use parameter estimates inferred from confirmed case and vaccination time series via stochastic ensemble Kalman filtering in each territory. Our analyses suggest viral immune resistance was most likely to emerge in Texas, which relied almost exclusively on vaccines for disease control. In contrast, regions with comparatively fewer health disparities that also rigorously applied interventions, such as shelter-in-place orders and household support, may have better prevented vaccine resistance from evolving. These comparative analyses highlight the key role policy choices play, potentially representing different governance goals for population health and wellbeing. We argue that such choices impact not only disease spread but also pathogen evolution along epidemiologically critical dimensions like viral immune susceptibility. Our study thus demonstrates how public health priorities drive social-evolutionary feedbacks.

Indexed as

COVID-19Immune EvasionPublic HealthSARS-CoV-2AmericasHumansPandemicshealthcare and wellbeing systemsLatin Americasocial–evolutionary feedbacksvirus–vaccine evolution

Identifiers

PMID42515009
PMCPMC13414787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.